My watch list
my.bionity.com  
Login  

Proteogenix



Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.[1]

References

  1. ^ "ProteoGenix News from The BioSpace Beat", Biospace.com, September 29, 2004. 
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Proteogenix". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE